Simulations Plus

Record quarterly revenue, 9moFY16 diluted EPS increased 23% to a record $0.242 from $0.196

Conference Call to be on Thursday, July 14, at 4:15 PM ET

Release adds significant enhancements to unique software product

Record second quarter as revenues grow 12.9%, net income up 18%

Conference Call to be on Wednesday, April 13, at 4:15 PM ET

Project provides ~$4.7 million over 5 years to implement a platform for global teams engaged in model-based drug development

A new modeling visualization experience

Consolidated net revenues up 18.4%; net income increased 109%

Conference Call to be on Thursday, January 14, at 4:15 PM ET

Management to Present at LD Micro Conference in Los Angeles on December 2, and to Attend One-on-One Meetings at the Benchmark MicroCap Discovery Conference in Chicago on December 10

Full Fiscal Year Pharmaceutical Software and Services Up 59.8%; Earnings per share $0.23 cents up $0.05 cents (22.4%) over prior year

Conference Call to be on Wednesday, November 18, 2015, at 4:15 P.M. EST